Impact of COVID-19 Pandemic on Patients with Immune Thrombocytopaenia
Autor: | Sara García Barcenilla, Elena Monzón Manzano, Paula Acuña Butta, Beatriz de la Cruz Benito, Tamara Cebanu, Nora Butta, María Teresa Álvarez Román, Andres Lopez, Victor Jiménez Yuste, Mónica Martín Salces, María Isabel Rivas Pollmar, Roberto Trelles Martínez, Elena González Zorrilla |
---|---|
Přispěvatelé: | Hospital Universitario La Paz-IdiPaz, UAM. Departamento de Medicina, Instituto de Investigación Sanitaria Hospital Universitario de La Paz (IdiPAZ) |
Rok vydání: | 2021 |
Předmět: |
Adult
Male Risk medicine.medical_specialty Pediatrics Medicine (General) Medicina Population Article Medication Adherence Cohort Studies Young Adult R5-920 immune system diseases hemic and lymphatic diseases immune thrombocytopaenia Epidemiology Medicine Humans Cumulative incidence Young adult education Aged Quality of Health Care Aged 80 and over education.field_of_study Purpura Thrombocytopenic Idiopathic Immune thrombocytopaenia business.industry SARS-CoV-2 Incidence (epidemiology) Incidence COVID-19 vulnerable population telemedicine General Medicine Middle Aged Telemedicine Spain Vulnerable population Cohort Female business Psychosocial Delivery of Health Care Immunosuppressive Agents Cohort study |
Zdroj: | Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid Consejería de Sanidad de la Comunidad de Madrid Medicina; Volume 57; Issue 3; Pages: 219 Medicina Volume 57 Issue 3 Biblos-e Archivo. Repositorio Institucional de la UAM instname Medicina, Vol 57, Iss 219, p 219 (2021) |
Popis: | Background and Objectives: The aim of this study was to determine the impact of the COVID-19 pandemic on the lives of patients with immune thrombocytopaenia (ITP) treated at our hospital. Materials and Methods: The study was conducted in the Community of Madrid, which has the highest number of COVID-19 cases in Spain. We included 143 adult patients with ITP (130 with chronic ITP, 8 with persistent ITP, and 5 with newly diagnosed ITP). We conducted a telephone survey to collect the data and created a registry. Materials and Methods: Overall, 24 patients presented symptoms suggestive of COVID-19, which was confirmed by RT-PCR in 8 cases. The cumulative incidence of confirmed SARS-CoV-2 infection was higher in the patients with ITP than in the Madrid population. There were no differences in the disease incidence or clinical course of infection in the patients treated with immunosuppressants. Almost all of the patients reported adherence to the prescribed treatment, although 49.2% of the hospital visits were either cancelled or postponed, 17.2% because of the patients’ fear of coming to the centre. Nearly half of the cohort was considered vulnerable, and 17% had been granted a dependency or disability benefit. Conclusions: COVID-19 had a major impact on the psychosocial, occupational, and quality of care of patients with ITP. This study was supported by FIS-Fondos FEDER PI19/00631 and PI19/00772 and by the Platelet Disorder Support Association |
Databáze: | OpenAIRE |
Externí odkaz: |